{
    "Symbol": "PODD",
    "AssetType": "Common Stock",
    "Name": "Insulet Corporation",
    "Description": "Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.",
    "CIK": "1145197",
    "Exchange": "NASDAQ",
    "Currency": "USD",
    "Country": "USA",
    "Sector": "LIFE SCIENCES",
    "Industry": "SURGICAL & MEDICAL INSTRUMENTS & APPARATUS",
    "Address": "9 OAK PARK DRIVE, BEDFORD, MA, US",
    "FiscalYearEnd": "December",
    "LatestQuarter": "2022-12-31",
    "MarketCapitalization": "21494831000",
    "EBITDA": "126000000",
    "PERatio": "5151.5",
    "PEGRatio": "3.323",
    "BookValue": "6.85",
    "DividendPerShare": "0",
    "DividendYield": "0",
    "EPS": "0.06",
    "RevenuePerShareTTM": "18.82",
    "ProfitMargin": "0.0035",
    "OperatingMarginTTM": "0.0481",
    "ReturnOnAssetsTTM": "0.0183",
    "ReturnOnEquityTTM": "0.0089",
    "RevenueTTM": "1305300000",
    "GrossProfitTTM": "805600000",
    "DilutedEPSTTM": "0.06",
    "QuarterlyEarningsGrowthYOY": "-0.402",
    "QuarterlyRevenueGrowthYOY": "0.201",
    "AnalystTargetPrice": "335.07",
    "TrailingPE": "5151.5",
    "ForwardPE": "256.41",
    "PriceToSalesRatioTTM": "16.71",
    "PriceToBookRatio": "49.06",
    "EVToRevenue": "17.44",
    "EVToEBITDA": "178.89",
    "Beta": "0.744",
    "52WeekHigh": "320",
    "52WeekLow": "181",
    "50DayMovingAverage": "293.1",
    "200DayMovingAverage": "265.59",
    "SharesOutstanding": "69542000",
    "DividendDate": "None",
    "ExDividendDate": "None"
}